Risk assessment for the spread of Candida sp. in dental chair unit waterlines using molecular techniques

Int Dent J. 2018 Dec;68(6):386-392. doi: 10.1111/idj.12401. Epub 2018 May 4.

Abstract

Aims: The aim of this study was to evaluate the presence of yeasts in dental chair unit waterlines (DCUWLs) and to test their ability to form biofilms.

Materials and methods: Eighteen dental waterlines were analysed by culture in liquid Sabouraud in order to allow the quantification and the purification of isolated yeasts from their internal surfaces. All isolates were identified by standard laboratory procedures, including CHROMagar Candida medium for orientation, commercial yeast identification system Api Candida, MALDI-TOF MS and DNA sequencing. To evaluate their kinetics of antifungal susceptibility during different phases of biofilm formation, these yeasts were subjected to three antifungal agents.

Results: From the 18 DCUWLs studied, 10 were altered (55.56%). Eleven strains of Candida sp. [Candida albicans (2), Candida guilliermondii (5) and Candida glabrata (4)] and two species of non-Candida; Rhodotorula spp. (1) and Trichosporon spp. (2) were identified. The majority of yeasts in planktonic form were susceptible to amphotericin B, caspofungin and voriconazole, except C. albicans was resistant to voriconazole. In the biofilm form, caspofungin was the most effective antifungal agent for all isolated strains. For the other antifungal agents, sessile cells were resistant.

Conclusion: Several types of yeasts were identified; the most frequently isolated genus was Candida. The majority of these yeasts had the ability to form biofilms and resisted antifungal agents used in this study.

Keywords: Dental public health; antimicrobial resistance; biofilm; molecular genetics; mycology.

MeSH terms

  • Amphotericin B / pharmacology
  • Antifungal Agents / pharmacology*
  • Biofilms* / drug effects
  • Candida / drug effects
  • Candida / isolation & purification*
  • Candida / physiology
  • Cross Infection
  • Dental Equipment / microbiology*
  • Drug Resistance, Fungal*
  • Equipment Contamination*
  • Fluconazole / pharmacology
  • Humans
  • Risk Assessment
  • Sequence Analysis, DNA

Substances

  • Antifungal Agents
  • Amphotericin B
  • Fluconazole

Associated data

  • GENBANK/KC119207.1
  • GENBANK/JQ678690.1
  • GENBANK/CR380958.2